Involuntary Emotional Expressive Disorder: A Case for a Deeper Neuroethics

Neurotherapeutics

Volumn 4, Issue 3, 2007, Pages 560-567

  Whitehouse, Peter J ^a   Waller, Sara ^a  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

bioethics; dementia; diagnosis; IEED; Neuroethics; neuropsychiatric conditions

Indexed keywords

ALZHEIMER DISEASE; ARTICLE; INVOLUNTARY EMOTIONAL EXPRESSIVE DISORDER; MEDICAL ETHICS; MORALITY; PRIORITY JOURNAL; SOCIAL ASPECT; SYNDROME;

EID: 34250737296     PISSN: 19337213     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nurt.2007.03.003     Document Type: Article

References (30)

1. Caplan P., and Gans M. Is there empirical justification for the category of 'self defeating personality disorder'?. Fem Psychol 1 (1991) 263-278
2. American Psychiatric Association. Diagnostic and statistical manual of mental disorders (DSM-IV). 4th ed. (1994), APA, Washington, DC
3. Waller S. The Wisconsin Card Sort: an empirical and philosophical analysis of presuppositions regarding flexibility of cognition. In: Figueroa R., and Harding S. (Eds). Science and other cultures: issues in philosophies of science and technology (2003), Routledge, New York 189-200
4. Berrios G.E. Alzheimer's disease: a conceptual history. Int J Geriatr Psychiatry 5 (1990) 355-365
5. Alzheimer A. Über eine eigenartige Erkrankung der Hirnrinde. [In German]. Allg Z Psychiatrie 64 (1907) 146-148
6. Alzheimer A., Stelzmann R.A., Schnitzlein H.N., and Murtagh F.R. An English translation of Alzheimer's 1907 paper, "Uber eine eigenartige Erkankung der Hirnrinde.". Clin Anat 8 (1995) 429-431
7. In: Whitehouse P.J., Maurer K., and Ballenger J. (Eds). Concepts of Alzheimer disease: biological, clinical, and cultural perspectives (2000), Johns Hopkins Press, Baltimore 48-128
8. Sachdev P. Is it time to retire the term "dementia?". J Neuropsychiatry Clin Neurosci 12 (2000) 276-279. http://www.neuro.psychiatryonline.org/cgi/content/full/12/2/276 [Available at http://www.neuro.psychiatryonline.org/cgi/content/full/12/2/276].
9. Whitehouse P.J. The end of Alzheimer disease. Alzheimer Dis Assoc Disord J 15 (2001) 59-62
10. Gaines A.D., and Whitehouse P.J. Building a mystery: Alzheimer disease, mild cognitive impairment, and beyond. Philos Pychiatry Psychol 13 (2006) 61-74
11. Morris J.C. Mild cognitive impairment is early-stage Alzheimer disease. Arch Neurol 63 (2006) 15-16
12. Whitehouse P.J., and Juengst E.T. Anti-aging medicine and mild cognitive impairment: practice and policy issues for geriatrics. J Am Geriatr Soc 53 (2005) 1417-1422
13. Darwin C. The expression of the emotions in man and animals (1873), Appleton, New York
14. Cummings J.L., Arciniegas D.B., Brooks B.R., et al. Defining and diagnosing involuntary emotional expressive disorder. CNS Spectr 11 (2006) 1-7
15. Pollack A.W. Marketing a disease, and also a drug to treat it. New York Times (2005). http://www.nytimes.com May 9 [Available at http://www.nytimes.com].
16. Panitch H.S., Thisted R.A., Smith R.A., et al. Randomized, controlled trial of dextromethorphan/quinidine for pseudobulbar affect in multiple sclerosis. Ann Neurology 59 (2006) 780-787
17. Brooks B.R., Thisted R.A., Appel S.H., et al. Treatment of pseudobulbar affect in ALS with dextromethorphan/quinidine: a randomized trial. Neurology 63 (2004) 1364-1370
18. Starkstein S.E., Migliorelli R., Teson A., et al. Prevalence and clinical correlates of pathological affective display in Alzheimer's disease. J Neurol Neurosurg Psychiatry 59 (1995) 55-60
19. Arciniegas D.B., Lauterbach E.C., Anderson K.E., et al. The differential diagnosis of pseudobulbar affect (PBA): distinguishing PBA among disorders of mood and affect. Proceedings of a roundtable meeting. CNS Spectr 10 (2005) 1-14
20. Avanir Pharmaceuticals. A national discussion about a debilitating condition. PBA Update (2005) 2 (February issue).
21. Potter V.R. Bioethics: bridge to the future (1971), Prentice-Hall, Englewood Cliffs, NJ
22. Potter V.R. Global bioethics: building on the Leopold legacy (1988), Michigan State University Press, East Lansing, MI
23. Whitehouse P.J. The rebirth of bioethics: extending the original formulations of Van Rensselaer Potter. American J Bioethics 3 (2003) W26-W31
24. Whitehouse P. Van Rensselaer Potter: an intellectual memoir. Camb Q Healthc Ethics 11 (2002) 331-334
25. Potter V.R., and Whitehouse P.J. Deep and global bioethics for a livable third millennium. Scientist 12 (1998) 1-9
26. Tong R. Teaching bioethics in the new millennium: holding theories accountable to actual practices and real people. J Med Philos 27 (2002) 417-432
27. Murphy T.F. Representation and balance on presidential commissions. Am Philos Assoc Newsl Philos Med [online serial] (2005) 04. http://www.apa.udel.edu/apa/publications/newsletters/MedicineNL/v04n2.htm [Available at: http://www.apa.udel.edu/apa/publications/newsletters/MedicineNL/v04n2.htm].
28. Illes J., and Racine E. Imaging or imagining?. A neuroethics challenge informed by genetics. Am J Bioethics 5 (2005) 5-18
29. Pierce J., and Jameton A. The ethics of environmentally responsible health care (2001), Oxford University Press, New York
30. Baker R. A draft model aggregated code of ethics for bioethicists. Am J Bioeth 5 (2005) 33-41